INTS4L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.858300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.110400E-01
Normal-vs-Stage2
4.020600E-03
Normal-vs-Stage3
1.432360E-01
Normal-vs-Stage4
1.032190E-01
Stage1-vs-Stage2
4.536600E-01
Stage1-vs-Stage3
9.363800E-02
Stage1-vs-Stage4
7.576000E-01
Stage2-vs-Stage3
3.87890000008717E-07
Stage2-vs-Stage4
7.058200E-01
Stage3-vs-Stage4
4.821700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.480800E-01
Normal-vs-AfricanAmerican
3.889000E-01
Normal-vs-Asian
1.767810E-01
Caucasian-vs-AfricanAmerican
5.110400E-01
Caucasian-vs-Asian
6.132200E-02
AfricanAmerican-vs-Asian
2.302400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.501800E-01
Normal-vs-Female
4.777100E-03
Male-vs-Female
7.886600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.770650E-01
Normal-vs-Age(41-60Yrs)
6.937200E-03
Normal-vs-Age(61-80Yrs)
3.864700E-03
Normal-vs-Age(81-100Yrs)
1.875190E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.059000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.061200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.095000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.361400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.803800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.434280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.221200E-01
Normal-vs-Daily Drinker
9.335600E-02
Normal-vs-Weekly Drinker
1.849020E-01
Normal-vs-Occasional Drinker
3.202100E-02
Normal-vs-Social Drinker
3.019600E-01
Non Drinker-vs-Daily Drinker
2.234600E-01
Non Drinker-vs-Weekly Drinker
2.616800E-01
Non Drinker-vs-Occasional Drinker
2.535600E-01
Non Drinker-vs-Social Drinker
1.319370E-01
Daily Drinker-vs-Weekly Drinker
5.210100E-02
Daily Drinker-vs-Occasional Drinker
7.932400E-01
Daily Drinker-vs-Social Drinker
9.792600E-01
Weekly Drinker-vs-Occasional Drinker
7.043500E-02
Weekly Drinker-vs-Social Drinker
2.436300E-02
Occasional Drinker-vs-Social Drinker
7.823000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.952800E-01
Normal-vs-Grade 2
1.981760E-01
Normal-vs-Grade 3
1.851000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.384380E-01
Grade 1-vs-Grade 3
5.378100E-02
Grade 1-vs-Grade 4
3.952800E-01
Grade 2-vs-Grade 3
3.275200E-01
Grade 2-vs-Grade 4
1.981760E-01
Grade 3-vs-Grade 4
1.851000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.133800E-01
Normal-vs-NonDiabetic
1.050260E-02
Diabetic-vs-NonDiabetic
1.034640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.827610E-01
Normal-vs-NoPancreatitis
3.195900E-03
Pancreatitis-vs-NoPancreatitis
3.985800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.262000E-01
Normal-vs-N1
6.920600E-03
N0-vs-N1
1.975570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.918200E-01
Normal-vs-TP53-NonMutant
3.065800E-01
TP53-Mutant-vs-TP53-NonMutant
1.597810E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
